Editorial
doi: 10.5858/2013-0509-ED.
Phasing-in RHD genotyping
Affiliations
- PMID: 24786114
- PMCID: PMC5178138
- DOI: 10.5858/2013-0509-ED
Item in Clipboard
Editorial
Phasing-in RHD genotyping
Arch Pathol Lab Med.
2014 May.
No abstract available
Conflict of interest statement
WAF receives royalties and holds intellectual property rights for RHD genotyping. The other authors declare no competing interests relevant to this article.
Comment on
-
Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists.Arch Pathol Lab Med. 2014 May;138(5):620-5. doi: 10.5858/arpa.2013-0141-CP. Arch Pathol Lab Med. 2014. PMID: 24786120
Similar articles
-
Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists.Arch Pathol Lab Med. 2014 May;138(5):620-5. doi: 10.5858/arpa.2013-0141-CP. Arch Pathol Lab Med. 2014. PMID: 24786120
-
Rh Immune Globulin After the Transfusion of RhD-Positive Blood in a Patient with a Partial D Antigen.Obstet Gynecol. 2022 Dec 1;140(6):1052-1055. doi: 10.1097/AOG.0000000000004981. Epub 2022 Nov 2. Obstet Gynecol. 2022. PMID: 36357991
-
Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles.Transfusion. 2021 Jan;61(1):256-265. doi: 10.1111/trf.16100. Epub 2020 Sep 25. Transfusion. 2021. PMID: 32975828
-
Rh Immunoprophylaxis for Women With a Serologic Weak D Phenotype.Lab Med. 2015 Summer;46(3):190-4. doi: 10.1309/LMUNUP4FJTUX2GCD. Lab Med. 2015. PMID: 26199257 Review.
-
[Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].J Gynecol Obstet Biol Reprod (Paris). 2006 Feb;35(1 Suppl):1S123-1S130. J Gynecol Obstet Biol Reprod (Paris). 2006. PMID: 16495838 Review. French.
Cited by
-
Blood Group Testing.Front Med (Lausanne). 2022 Feb 11;9:827619. doi: 10.3389/fmed.2022.827619. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35223922 Free PMC article. Review.
-
Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors.Blood Transfus. 2019 Mar;17(2):151-156. doi: 10.2450/2018.0153-18. Epub 2018 Oct 24. Blood Transfus. 2019. PMID: 30418133 Free PMC article.
-
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013.Blood Transfus. 2015 Jul;13(3):514-20. doi: 10.2450/2014.0213-14. Epub 2014 Dec 2. Blood Transfus. 2015. PMID: 25545874 Free PMC article. No abstract available.
-
It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.Transfusion. 2015 Mar;55(3):680-9. doi: 10.1111/trf.12941. Epub 2014 Dec 1. Transfusion. 2015. PMID: 25438646 Free PMC article. No abstract available.
References
-
- Sandler SG, Roseff SD, Domen RE, Shaz BH, Gottschall JL. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin. Arch Pathol Lab Med. 2013;137(Dec 2013) in press. - PubMed
-
- Carson TH. Standards for Blood Banks and Transfusion Services. 28. Bethesda MD: AABB; 2012.
-
- Kennedy MS. Perinatal issues in transfusion practice. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical Manual. 18. Bethesda: AABB; 2012. pp. 637–650.
-
- Sandler SG, Mozurkewich EL. Ask the Experts: Postpartum Rh immunoprophylaxis. Obstet Gynecol. 2012;120 - PubMed
-
- Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood. 1999;93(1):385–393. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
